ABOUT COLOGUARD
Cologuard is a one-of-a-kind,
non-invasive colon cancer screening test.†
92%
Cologuard finds 92% of colon cancers overall1
94%
Cologuard finds 94% of Stage I & Stage II colon cancers2
90%
When caught in early stages, colon cancer is treatable in about 90% of people3
GETTING SCREENED
Who should get screened?
HOW TO USE COLOGUARD
See how easy it is to use Cologuard at home
- English (US)
- English (US)
- Español (Spanish)
- العربية (Arabic)
- 粵語 (Cantonese Chinese)
- Français (French)
- Kreyòl Ayisyen (Haitian Creole)
- हिंदी (Hindi)
- 한국어 (Korean)
- 国语 (Mandarin Chinese)
- Português (Portuguese)
- Русский (Russian)
- Tagalog/Filipino
- Tiếng Việt (Vietnamese)
UNDERSTANDING RESULTS
Know what next steps to take
Cologuard is a screening test that looks for altered DNA and/or blood that could be signs of precancerous growths or colorectal cancer. Getting screened is always a good choice because your result can guide your path forward..
A negative result means Cologuard
did not detect these potential signs
- Cologuard did not detect altered DNA and/or blood in your stool
- You're unlikely to have colorectal cancer
- When you discuss your result with a healthcare provider, ask when you should screen again.
A positive result means these
potential signs were detected
- Cologuard detected altered DNA and/or blood in your stool
- This could be due to precancerous growths, colorectal cancer, or some other reason
- It’s important to know that this is not the same as a cancer diagnosis
- When you discuss your result with a healthcare provider, you will need to plan a colonoscopy to confirm your result.
HOW TO GET COLOGUARD
Request Cologuard
without leaving your home
FAQs
You have questions.
We have answers.
-
What is Cologuard?
Cologuard is an FDA-approved, non-invasive, at-home colon cancer screening test. It’s for people 45 or older at average risk for colon cancer. RX only.
Learn More About Cologuard -
Who is Cologuard for?
Cologuard is for adults at average risk for colon cancer. Cologuard is not a replacement for colonoscopy in high-risk individuals.
Read How Cologuard Works -
How does Cologuard work?
Cologuard uses advanced stool technology to detect the DNA and blood cells released from abnormal cells, and can detect both precancer and cancer.
Learn More -
How effective is Cologuard?
Cologuard found 92% of all colon cancers (and 94% of all stage I & II cancers) in a clinical study of 10,000 participants ages 50-84 years old, of average risk for colorectal cancer.
Learn More -
How do I get Cologuard?
You can request Cologuard through your healthcare provider. Requesting Cologuard through an online telehealth provider is also an option.
Click Here To Get Started
Reference
-
- 1.
Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297. -
- 2.
Ahlquist DA. Multi-target stool DNA test: a new high bar for noninvasive screening. Dig Dis Sci. 2015;60(3):623-633. -
- 3.
National Cancer Institute. SEER cancer stat facts: colorectal cancer. Accessed Jan 1, 2023. https://seer.cancer.gov/statfacts/html/colorect.html -
- 4.
American Cancer Society. When should you start getting screened for colorectal cancer? Published February 4, 2021. Accessed Jan 1, 2023. https://www.cancer.org/latest-news/american-cancer-society-updates-colorectal-cancer-screening-guideline.html -
- 5.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023.CA Cancer J Clin. 2023;73(1):17-48. -
- 6.
American Cancer Society. Can Colorectal Polyps and Cancer Be Found Early? Updated June 29, 2020. Accessed April 25, 2023. https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/detection.html -
- 7.
American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.
Footnote
-
- †
Cologuard sensitivity, per stage of cancer: I: 90% (n=29); II: 100% (n=21); III: 90% (n=10); IV: 75% (n=4). Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. False positives and false negatives may occur. In this clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative).